Leveraging its three major technology platforms—modular stent design, biomedical materials, and active medical devices—Endovas Medical has filed over 100 patents (including more than 20 granted invention patents) and 12 software copyrights. The company's R&D team consists of multidisciplinary experts in materials science, mechanical engineering, electrical engineering, clinical medicine, and related fields. The core team members have an average of over 15 years of experience in vascular interventional device R&D. Through collaborations with institutions such as Fudan University, Shanghai Ninth People's Hospita, Changhai Hospital, and Xiangya Hospital of Central South University, EndoVas has established an industry-academia-research collaborative innovation mechanism, with annual R&D investment exceeding ten million yuan.
Founded in November 2018, Shanghai Ensheng Medical Technology Co., Ltd. is located at No. 356, Zhengbo Road, Lingang New Area, China (Shanghai) Pilot Free Trade Zone. The company occupies an office building of over 2,300 square meters and a 1,000-square-meter GMP Class 10,000 clean workshop. Recognized as a "Specialized and Sophisticated SME" focusing on the treatment of peripheral venous diseases, the company operates under the mission: "Bringing Benefit to the Public, Winning Reputation through Excellence." Ensheng has successfully established a comprehensive peripheral venous solution centered on key products including the deep vein thrombosis removal system, venous stent, and venous closure system for varicose veins.
switchboard：+86 21 33658866
Scan to follow the official account
